...
首页> 外文期刊>Journal of Anaesthesiology Clinical Pharmacology >Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy
【24h】

Is there an interaction between dexamethasone and sugammadex in real clinical conditions? A randomized controlled trial in patients undergoing laparoscopic cholecystectomy

机译:在真实的临床情况下,地塞米松和舒马格德之间是否存在相互作用?腹腔镜胆囊切除术患者的随机对照试验

获取原文

摘要

Background and Aims: There is evidence that sugammadex can encapsulate other substances except rocuronium, such as dexamethasone. The aim of this study was to investigate the possible clinical interaction between dexamethasone and sugammadex, in patients undergoing laparoscopic cholecystectomy. Material and Methods: This was a randomized, double-blind controlled trial, performed in patients aged 18–75 years, American Society of Anesthesiologists (ASA) I–III, who underwent a laparoscopic cholecystectomy under deep neuromuscular blockade with rocuronium. Patients received 5 mg of dexamethasone or placebo (N/S 0.9%) during induction of anesthesia. Sugammadex 4 mg/kg was administered at the end of surgery at post-tetanic count 1–2. The outcome measures assessed were the time from sugammadex administration until train-of-four (TOF) 0.9, and until patient's extubation, postoperative pain (measured by numeric rating scale 0–10), nausea and vomiting, as well as rescue analgesics and antiemetics required during the first 24 hours postoperatively. The total dose of rocuronium required in both groups was also recorded. Results: Overall, 44 patients were studied. No difference was detected regarding the demographic and surgical characteristics of patients. The time from sugammadex administration until TOF 0.9 and until patients' extubation did not differ significantly between the groups (P = 0.21 and 0.17). Operating conditions, pain scores, nausea/vomiting, and rescue analgesics and antiemetics during the first 24 hours postoperatively, did not differ between the groups. The total dose of rocuronium, however, was significantly more in patients who received dexamethasone (P = 0.01). Conclusion: No significant clinical interaction was revealed between dexamethasone and sugammadex during reversal of deep neuromuscular blockade in patients undergoing laparoscopic cholecystectomy.
机译:背景和目的:有证据表明,舒马得克斯可以包裹罗库溴铵以外的其他物质,例如地塞米松。这项研究的目的是调查在接受腹腔镜胆囊切除术的患者中地塞米松和舒马葡糖之间可能的临床相互作用。材料与方法:这是一项随机,双盲对照试验,在美国麻醉医师学会(ASA)I–III年龄18-75岁的患者中进行,该患者在接受罗库溴铵的深层神经肌肉阻滞下接受了腹腔镜胆囊切除术。在麻醉诱导期间,患者接受了5 mg地塞米松或安慰剂(N / S 0.9%)。 Sugammadex 4 mg / kg在手术结束时以强直后计数1-2服用。评估的结局指标是从给予舒加美葡糖到四轮训练(TOF)0.9的时间,直至患者拔管,术后疼痛(以数字等级量表0-10衡量),恶心和呕吐以及抢救性止痛药和止吐药的时间。术后头24小时内需要。还记录了两组中所需的罗库溴铵的总剂量。结果:总共研究了44例患者。在患者的人口统计学和手术特征方面未发现差异。两组之间,从舒马丙肽给药至TOF 0.9直至患者拔管的时间无显着差异(P = 0.21和0.17)。两组之间的手术条件,疼痛评分,恶心/呕吐以及急救镇痛药和止吐药在两组之间没有差异。然而,接受地塞米松的患者罗库溴铵的总剂量明显更高(P = 0.01)。结论:在进行腹腔镜胆囊切除术的患者深部神经肌肉阻滞逆转期间,地塞米松和舒糖葡聚糖之间无显着临床相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号